Malvern Cosmeceutics Ltd leads the way in revolutionizing the cosmetic industry. Our Lipodisq® technology is seamlessly integrated into cosmetic formulations, offering enhanced active delivery, prolonged product efficacy, and a heightened user experience.
In the field of membrane protein research, Lipodisq® nanotechnology assumes a critical role in analytical processes and research applications. Lipodisq® not only enables the extraction of native membrane proteins, including GPCRs, but also stabilizes them for in-depth analytical studies. This breakthrough technology is instrumental in advancing the design of novel drug molecules and drug/receptor interaction studies. The advancement of this facet of our technology has been propelled by the numerous academic and industrial researchers worldwide who have leveraged this technology, continually contributing to a deeper understanding of its capabilities.
Malvern Cosmeceutics Ltd extends its Lipodisq® expertise to the nutraceutical industry. Our solutions enhance the bioavailability of nutritional active ingredients, ensuring enhanced absorption and effectiveness in nutraceutical formulations that promote health and wellness.
In the pharmaceutical sector, Malvern Cosmeceutics Ltd is driving advancements in drug delivery and therapeutic solutions. Our Lipodisq® technology enables targeted drug delivery, improving treatment efficacy while minimizing side effects. We are dedicated to accelerating breakthroughs in healthcare through our innovative approach.